UMB Bank’s Immix Biopharma IMMX Stock Holding History

UMB Bank’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-72,639	Closed	-$195K	–	1724
2023 Q2	$195K	Sell	72,639 -26,661	-27%	-$55.8K	﹤0.01%	583
2023 Q1	$181K	Buy	+99,300	New	+$219K	﹤0.01%	587

Other funds holding IMMX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Imprint Wealth Mount Pleasant, South Carolina $24.6M AUM 43.43% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ICG

InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

UMB Bank's IMMX Position: Q3 2023 in Review

UMB Bank sold out of Immix Biopharma (IMMX) in Q3 2023, closing a stake of 72,639 shares — an estimated $195K sold.

UMB Bank first reported a position in IMMX in Q1 2023 and held it in 2 quarters. The position peaked at $195K in Q2 2023. 16 funds tracked by Wall St. Rank hold IMMX as of Q3 2023.

UMB Bank reported no remaining Immix Biopharma position as of Q3 2023 after selling out during the quarter.
UMB Bank sold 72,639 Immix Biopharma shares in Q3 2023, an estimated $195K.
UMB Bank first reported a position in Immix Biopharma in Q1 2023 and held it in 2 quarters.
UMB Bank's Immix Biopharma position peaked at $195K in Q2 2023.
16 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2023.

Based on UMB Bank's 13F filing for Q3 2023, filed 18 Oct 2023.